Healthcare Industry News: fractional skin resurfacing
News Release - May 31, 2012
Solta Medical Announces Latest Advance in Fraxel(R) Laser TechnologyNew Fraxel Re:Pair SST Platform Provides Single Treatment with Unmatched Treatment Speed, Offering Physicians and Their Patients a Total Ablative Resurfacing Solution for Dermatological Anti-aging Indications
HAYWARD, Calif., May 31, 2012 -- (Healthcare Sales & Marketing Network) -- Solta Medical, Inc. (SLTM), the pioneer in fractional resurfacing and a global market leader in aesthetic treatments, today announced the availability of the Fraxel re:pair SST Laser Platform in the United States. The updated platform addresses the major needs of aging and sun-damaged skin and offers physicians unmatched versatility and customization to treat a broad range of clinical indications. It also offers patients a fast, single-pass single-treatment option providing impressive resurfacing results with more comfort and minimal healing time than a traditional Fraxel re:pair treatment.
Unlike any other fractional laser system, Fraxel re:pair SST has four unique handpieces: two fractional handpieces for both shallow and deep fractional skin resurfacing needs and two fully ablative handpieces for incisional, debulking and full-coverage skin resurfacing treatments. The fractional handpieces include the improved FMDA™ (Fractional Micro-Dermal Ablation) 600 micron handpiece that allows for a 20-minute, high-coverage, single-pass treatment to address sun damage, fine lines, texture and tone. This procedure is well tolerated with minimal downtime and remarkable clinical results in as little as one week.
"Fraxel re:pair SST is a significant advance for both physicians and patients," said Cameron Rokhsar, MD, FAAD, FAACS, Assistant Clinical Professor at the Albert Einstein College of Medicine in New York, and founder of the New York Cosmetic, Skin & Laser Surgery Center. "It is the most versatile laser on the market and the results live up to the highest standards set by Solta Medical, the company that first developed fractional laser technology. I am particularly excited about offering the FDDA 600 micron option since many patients want the results of a traditional Fraxel re:pair treatment but do not have the time to either receive the treatment or go through the longer healing process."
Fraxel re:pair SST also provides the benefits and ease of Solta Medical's proprietary IOTS™ (Intelligent Optical Tracking System) which allows smooth and precise energy application as opposed to the stamping method of less advanced lasers.
"We are very pleased to include Fraxel re:pair SST as the latest offering in the Fraxel portfolio of products," said Stephen J. Fanning, President and Chief Executive Officer of Solta Medical, Inc. "Fraxel re:pair SST and Fraxel® Dual 1550/1927 respectively offer ablative and non-ablative solutions for dermatologists, plastic surgeons and clinicians worldwide. Since 2003, more than 800,000 Fraxel procedures have been safely performed in over 80 countries on patients of all ages, skin types and body areas, resulting in significant clinical outcomes and unmatched physician acceptance."
For more information on Solta Medical, please visit www.Solta.com.
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant™, body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO™. As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun-damaged skin. Using similar fractional laser technology, Clear + Brilliant is a unique, cost-effective treatment to prevent and improve the early signs of photoaging. For body contouring, Liposonix is a non-surgical treatment to reduce waist circumference with advanced high-intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat beneath the skin. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. Isolaz was the first laser or light-based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA-cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. More than two million procedures have been performed with Solta Medical's portfolio of products around the world. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
© 2012 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Isolaz, Clear + Brilliant, CLARO, Liposonix and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.
Source: Solta Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.